Director announcement
Blis Technologies Limited: Ground Floor, 442 Moray Place, Dunedin Central 9016, PO Box 2208, Dunedin 9044, New Zealand
T:+64 3 474 0988 E: info@blis.co.nz W: www.blis.co.nz
11 December 2023
Director announcement
Blis Technologies Limited (NZX:BLT) advises the appointment of Anita Johansen as a director of the
company with effect from 1 January 2024. She will replace Dr Jörn Andreas who will retire from the
board on 31 December 2023.
Anita Johansen joined Probi AB in April 2022 as Vice President Research & Development and was
appointed as CEO in March 2023. Prior to joining Probi, she held different leadership positions
within Ferrosan, Pfizer Consumer Healthcare; Novozymes OneHealth and USP Zdrowie. She brings
extensive experience in product development of science based and consumer relevant supplements
containing probiotics.
The board has determined that Anita Johansen is not an independent director due to her role as CEO
of Probi AB, which is a substantial product holder of Blis Technologies. She will formally offer herself
for re-election as a director at the 2024 annual shareholders’ meeting.
“It is our pleasure to welcome Anita to the board. Her extensive scientific and probiotic experience
as well as her strong business acumen will further enhance our existing board capabilities,” said
Geoff Plunket, Board Chair. “On behalf of the board, I also wish to acknowledge Jörn’s significant
contribution over the past year. Jörn brought invaluable international experience from different
senior executive and governance roles in large multinational companies.”
Ends
For further information, please contact:
Geoff Plunket
Chair
+64 21 229 8886
About Blis Technologies Ltd
Delivering proven health benefits through evidence-based, advanced probiotics
Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut.
Combining innovation with evidence-based research and the highest quality production controls enables
the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath),
immune support, teeth and gum health and skin health. BLIS
®
products are sold throughout New Zealand
and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at
www.blis.co.nz.
Website: www.blis.co.nz
Instagram: @blisprobiotics #blisk12 #blism18 #blisq24
Facebook: @BLISProbiotics
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- GEN — General Capital Limited: Appointment of New Director2023-12-17
“General Capital Limited Level 8, General Capital House, 115 Queen Street, Auckland CBD PO Box 1314, Shortland Street, Auckland, New Zealand. 1140. Phone +64 9 304 0145 General Capital (GEN:NZ) Appointment of New Director General Capital, the listed financial services g…”
- EBO — EBOS Group Limited: Notice of Annual Meeting and Proxy Form2023-09-19
“Notice of Annual Meeting 2023 EBOS Group Limited Notice is given that the annual meeting of shareholders of EBOS Group Limited (the Company) (Annual Meeting) will be held as a hybrid meeting at the Park Hyatt Auckland, 99 Halsey Street, Auckland, New Zealand and online via th…”
- SCT — Scott Technology Limited: Scott Announces FY23 Results2023-10-17
“AS AT 31 AUGUST 2023 STATUTORY INFORMATION Scott Technology Limited Page 94 DIRECTORS’ INTERESTS The company maintains an Interests Register in accordance with the Companies Act 1993 and the Financial Markets Conduct Act 2013. No interest disclosures for the purposes of secti…”